Lewy bodies in progressive supranuclear palsy

Keywords

Progressive supranuclear palsy, Locus coeruleus, Lewy body, Pathology, Reticular formation

References

• The pathology of the human locus ceruleus.D.M.A. Mann, P. O. Yates, Janet Hawkes — 1983
• Progressive supranuclear palsy: clinico-pathological and biochemical studies.K. A. Jellinger, Peter Riederer, M Tomonaga — 1980
• α-Synuclein in Lewy bodiesMaria Grazia Spillantini, Marie L. Schmidt, Virginia M.‐Y. Lee — 1997
• Neurofibrillary Degeneration in Progressive Supranuclear Palsy and Corticobasal DegenerationNicolas Sergeant, A. Wattez, André Delacourte — 1999
• Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer’s disease and Lewy body disordersMaria Luiza Gava Schmidt, John A. Martin, Virginia M.‐Y. Lee — 1996
• Progressive supranuclear palsy with Lewy bodiesHiroki Mori, Masahiro Yoshimura, M Tomonaga — 2004
• THE PATHOLOGY OF CERTAIN MEDULLARY NUCLEI IN PARKINSONISM.Mervyn J. Eadie — 1963
• Antibodies to α‐synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's diseaseCarol F. Lippa, Marie L. Schmidt, Virginia M.‐Y. Lee — 1999
• Lewy bodies are not increased in progressive supranuclear palsy compared with normal controlsYoshio Tsuboi, J. Eric Ahlskog, Hülya Apaydın — 2001
• Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.Kunimasa Arima, Shigeo Hirai, N Sunohara — 1999
• Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.Carol F. Lippa, Hideo Fujiwara, David M. A. Mann — 1998
• Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.Rejko Krüger, W. Kuhn, Thomas Müller — 1998
• Disease‐specific patterns of locus coeruleus cell lossDwight C. German, Kebreten F. Manaye, Charles L. White — 1992
• Validity and Reliability of the Preliminary NINDS Neuropathologic Criteria for Progressive Supranuclear Palsy and Related DisordersIrene Litvan, J.J. Hauw, John J. Bartko — 1996
• Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depressionVictoria Chan‐Palay, Esther Asan — 1989
• The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.W R Gibb, Andrew J. Lees — 1988
• Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.Mihael H. Polymeropoulos, Christian Lavedan, Elisabeth Leroy — 1997
• Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's diseaseGlenda M. Halliday, Y. W. Li, P. C. Blumbergs — 1990
• Progressive supranuclear palsyMaria Gearing, David A. Olson, Ray L. Watts — 1994
• Widespread occurrence of alpha-synuclein/NACP-immunoreactive neuronal inclusions in juvenile and adult-onset Hallervorden-Spatz disease with Lewy bodies.Wakabayashi, Yoshimoto, Fukushima — 1999

Cited by

• Cortical Alzheimer type pathology does not influence tau pathology in progressive supranuclear palsy.Kenichi Oshima, Dennis W. Dickson — 2009
• Autosomal recessive, early-onset Parkinson’s diseaseVincenzo Bonifati — 2003
• The Synaptic Function of α-SynucleinJacqueline Burré — 2015
• Coexistence of PSP and MSA: a case report and review of the literatureHirotake Uchikado, Anthony DelleDonne, Ryan J. Uitti — 2006
• A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation.Gloria E. Meredith, Glenda M. Halliday, Susan Totterdell — 2004
• ELEVATED TAUOPATHY AND ALPHA SYNUCLEIN PATHOLOGY IN POSTMORTEM PARKINSON’S DISEASE BRAINS WITH AND WITHOUT DEMENTIAJonathan Wills, Jessica M. Jones, Thomas Haggerty — 2010
• The Relationship between Parkin and Protein Aggregation in Neurodegenerative DiseasesPreeti J. Khandelwal — 2010
• Tuft-shaped astrocytes in Lewy body diseaseNozomi Hishikawa, Yoshio Hashizume, Mari Yoshida — 2005
• Lewy Bodies in Progressive Supranuclear Palsy Represent an Independent Disease ProcessHirotake Uchikado, Anthony DelleDonne, Zeshan Ahmed — 2006
• The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathyGünter U. Höglinger, Annie Lannuzel, Myriam Escobar Khondiker — 2005
• Identification of G-Protein Coupled Receptor Kinase 2 in Paired Helical Filaments and Neurofibrillary TanglesMakio Takahashi, Hirotake Uchikado, Domenico Caprotti — 2006
• Biomarker identification in neurologic diseases: improving diagnostics and therapeuticsKeith D. Coon, Travis Dunckley, Dietrich A. Stephan — 2004
• Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm.Spyridon Papapetropoulos — 2007
• Tauopathies and synucleinopathies: Do cerebrospinal fluid β-amyloid peptides reflect disease-specific pathogenesis?Brit Mollenhauer, Mirko Bibl, Hermann Esselmann — 2007
• Co-existence of Parkinson’s disease and progressive supranuclear palsy: case report and a review of the literatureK Abhinav, Laura Marsh, Barbara J. Crain — 2011
• Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy PathologyHeather Rigby, Brittany N. Dugger, Joseph G. Hentz — 2015
• The neurotoxin, MPP+, induces hyperphosphorylation ofTau, in the presence of α-Synuclein, in SH-SY5Y neuroblastoma cellsTetyana Duka, Anita Sidhu — 2006
• Midbrain catecholaminergic neurons co-express α-synuclein and tau in progressive supranuclear palsyMaría Elena Erro Aguirre, María Victoria Zelaya, Javier Sánchez‐Ruiz de Gordoa — 2015
• Different Tau Pathology Pattern in Two Clinical Phenotypes of Progressive Supranuclear PalsyK. A. Jellinger — 2008
• Interface between tauopathies and synucleinopathies: A tale of two proteinsWendy R. Galpern, Anthony E. Lang — 2006

Related papers

• Targeted overexpression of A53T-alpha-synuclein induces progressive neurodegeneration and electrophysiological changes of noradrenergic locus coeruleus neurons – A preclinical model of Parkinson's diseaseLina A. Matschke, Martin T. Henrich, Annette Stoehr — 2017
• Regional brain atrophy in progressive supranuclear palsy and Lewy body diseaseN. J. Cordato, Glenda M. Halliday, A. J. Harding — 2000
• Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disordersMelek Firat Altay, Alan King Lun Liu, Janice L. Holton — 2022
• Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseasesJohn E. Duda, Benoit I. Giasson, Meghann E. Mabon — 2002
• Alpha-synuclein truncation and diseaseCaroline Ritchie, Philip Thomas — 2012
• 13 C and 15 N Resonance Assignments of Alpha Synuclein Fibrils Amplified from Lewy Body Dementia TissueAlexander M. Barclay, Dhruva D. Dhavale, Collin G. Borcik — 2023
• 13C and 15N Resonance Assignments of Alpha Synuclein Fibrils Amplified from Lewy Body Dementia TissueAlexander M. Barclay, Dhruva D. Dhavale, Collin G. Borcik — 2023
• Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disordersMelek Firat Altay, Alan King Lun Liu, Janice L. Holton — 2022
• The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body DisordersDavid J. Irwin, Howard I. Hurtig — 2018